Freelancers : Wyoming, Michigan

1 Kudos

5.0 2 Skills

Ask Rate/Hr

I love to translate complex concepts and content into readable prose for any audience and can meet short deadlines. I write on anything but specialize in science, medicine and health, including drug R&D. I also edit scientific and technical articles for publication in multiple forms, including peer-reviewed scientific and clinical journals. I have a Ph.D in Medicine and Physiology from London University and I have lived in the US since 1989. I have spent 18 years as a pharmaceutical executive and the last 6 in consulting, writing and editing. CURRENT ACTIVITY -Focus on health, wellness and pharmaceuticals. Specialist in all therapeutic areas, translational medicine, personalized medicine. -Consulting: Independent business and communications consulting for health related companies: Focus on health communications, patient experience of health and disease, in personalized medicine, translational health sciences, disease management. -Writing/Communications: Writing/editing/presenting including investor materials, business plans, patient and physician education materials, white papers, reports, grant applications and scientific articles. All therapeutic areas. - Clients include: Merrimack Pharmaceuticals, Phillip Morris International, GE Healthcare, Open Innovators, Sanofi, Woodrow Wilson Center, Alternative Futures Association. PRIOR EXPERIENCE -Open Innovators, CT. Medical Director (2007-present) *Knowledge strategy development for diabetic retinopathy, macular degeneration and other retinal diseases. SBIR+NSF grants obtained. -Pfizer Global Research and Development, New London, CT (1999-2006) *Senior Director and Head of Science, Communications and Technology for World Wide Drug Safety. Worldwide leadership of Technology Evaluation, Communications, Scientific *Creator and leader of Pfizer Futures Intelligence Network. Creation of a cross-company network of senior executives with the remit to create evergreen future healthcare scenarios with associated implications for the pharmaceutical industry and for Pfizer, and to incorporate insights into annual strategy setting activities. -Searle/Monsanto Corporation, St Louis, MO (1994-1999) *Director of Knowledge Management, Bioinformatics and Communications for Monsanto Corporate *Liaison between Monsanto and Washington University for $5M annual granting process for translation of basic science to potential therapeutics *Thrombosis Research Group Leader: Development and implementation of drug discovery platform for anti-thrombotic therapies. 20 direct reports. -Astra Zeneca (previously ICI Pharmaceuticals), UK (1982-1986). *Experimental Officer in heart failure and blood pressure research TEACHING EXPERIENCE *SMR International, NY (2008-2009). Teaching executive courses for Knowledge Services *Mitchell College, New London, CT (2007). Teaching course in clinical trial design *Washington University School of Medicine, St Louis, MO (1989-1994). Instructor in Cardiovascular Sciences in the Dept Internal Medicine. Teaching experience in surgical techniques and in biological sciences. Participation in NIH SCOR program and acquisition of R01 NIH research grant. VOLUNTEER ACTIVITY *The Gemma E Moran United Way New London Food Center, CT, Head of vision and strategy development for the New London food system. (2007-present). *Co-founder and knowledge strategist for New London Food Policy Council (January 2011- present). EDUCATION -St George’s Hospital Medical School, London University, London, UK 1986-1989. Doctor of Philosophy Degree awarded in Medicine and Physiology. Thesis entitled “Effect of anti-platelet compounds in experimental models of thrombosis and myocardial infarction” (First year completed at Bath University, Bath, UK) -Nottingham Trent University, Nottingham, UK 1978-1982. B.Sc (with honours) in Applied Biology. Specialist areas; Physiology, Pharmacology, Toxicology, Microbiology, Medical Microbiology PROFESSIONAL AFFILIATIONS • National Coalition of Independent Scholars • Professional Member of the American Diabetes Association • Cambridge Who’s Who • New York Academy of Sciences • Society of Competitive Intelligence Professionals • Institute for Noetic Sciences • Integral Institute • American Association for the Advancement of Science • World Futures Society • Society of Toxicology • Board Member, Gemma E Moran United Way Food Center, New London, CT • Editorial Board, Personalized Medicine, Future Science Group, London PUBLICATIONS 1. Torr-Brown, S. Regulatory and Ethical Challenges of Personalized Medicine. 7(5), 465-468, 2010. 2. Torr-Brown, S. Advances in Knowledge Management for Pharmaceutical Research and Development. Current Opinion in Drug Discovery and Development. 8 (3), 316-322, 2005, May. 3. Torr-Brown SR. Sobel BE. Antiplatelet effects of urokinase and their clinical implications. Coronary Artery Disease. 7(1):63-8, 1996 Jan. 4. Abendschein DR. Meng YY. Torr-Brown S. Sobel BE. Maintenance of coronary patency after fibrinolysis with tissue factor pathway inhibitor. Circulation. 92(4):944-9, 1995 Aug 15. 5. Torr-Brown SR. Sobel BE.Plasminogen activator inhibitor is elevated in plasma and diminished in platelets in patients with diabetes mellitus. Thrombosis Research. 75(4):473-7, 1994 Aug 15. 6. Torr-Brown SR. Nachowiak D. Fujii S. Sobel BE.Lack of degradation of antithrombin III by tissue-type plasminogen activator or plasmin. Coronary Artery Disease. 5(7):625-31, 1994 Jul. 5. Torr-Brown SR. Sobel BE. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets. Thrombosis Research. 72(5):413-21, 1993 Dec 1. 8. Prager NA. Torr-Brown SR. Sobel BE. Abendschein DR. Maintenance of patency after thrombolysis in stenotic coronary arteries requires combined inhibition of thrombin and platelets. Journal of the American College of Cardiology. 22(1):296-301, 1993 Jul. 9. Torr SR. Nachowiak DA. Fujii S. Sobel BE. "Plasminogen steal" and clot lysis. Journal of the American College of Cardiology. 19(5):1085-90, 1992 Apr. 10. Torr SR. Eisenberg PR. Sobel BE. The dependence of activation of platelets by a plasminogen activator on the evolution of thrombin activity. Thrombosis Research. 64(4):435-44, 1991 Nov 15. 11. Torr SR. Haskel EJ. VonVoigtlander PF. Bergmann SR. Abendschein DR.Inhibition of cyclic flow variations and reocclusion after thrombolysis in dogs by a novel antagonist of platelet-activating factor. Journal of the American College of Cardiology. 18(7):1804-10, 1991 Dec. 12. Haskel EJ. Torr SR. Day KC. Palmier MO. Wun TC. Sobel BE. Abendschein DR. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation. 84(2):821-7, 1991 Aug. 13. Torr SR. Winters KJ. Santoro SA. Sobel BE. The nature of interactions between tissue-type plasminogen activator and platelets. Thrombosis Research. 59(2):279-93, 1990 Jul 15. 14. Torr S. Noble MI. Folts JD. Inhibition of acute platelet thrombosis formation in stenosed canine coronary arteries by specific serotonin 5HT2 receptor antagonist ritanserin. Cardiovascular Research. 24(6):465-70, 1990 Jun. 15. Torr S. Drake-Holland AJ. Main M. Hynd J. Isted K. Noble MI. Effects on infarct size of reperfusion and pretreatment with beta-blockade and calcium antagonists. Basic Research in Cardiology. 84(6):564-82, 1989 Nov-Dec. 16. Collis MG. Keddie JR. Torr SR. Evidence that the positive inotropic effects of the alkylxanthines are not due to adenosine receptor blockade. British Journal of Pharmacology. 81(2):401-7, 1984 Feb.

3 Kudos

3.5 2 Skills

Ask Rate/Hr

I have a crazy passion for video editing and shooting. Also love photography. Great with Premiere 6, final pro x, photo shop, motion and ect.. Some what schooling but took a break. I am very knowledgeable about using dslrs and video formats. A very quick learner. Everyday and night is another day of learning for me from more camera tricks and movements to lighting and effects.

10 Kudos

5.0 2 Skills

$8 Rate/Hr

My name is Jing Cai. I was born in Shanghai, China. I have grown up in a highly artistic family. My family has been very supportive of me in developing my artistic and aesthetic skills. I have obtained a bachelor degree in landscape architecture. I have traveled all across China in order to expand my understanding on Chinese arts comprehensively. Upon my graduation from University, I embarked on my ethnographic field work in Japan. In China, so much of Chinese cultural treasures have been lost due to historical tragedy in recent history, however, the Japanese people were much more sophisticated in preserving the ancient Chinese cultures and arts. For this reason, I extensively traveled around Japan in collecting Chinese arts and in better understanding Japanese aesthetics. My experiences in Japan and China qualify me as an Oriental Cultural Expert. As a Landscape Architect, I have put so much effort in understanding historical techniques and skills in terms of how Japanese successfully preserved the ancient Chinese culture and arts as opposed to Chinese. In my field work in Kyoto and Nara, I have conducted extensive research on traditional Japanese and Chinese architectures and gardens. For example, the Japanese people created the best ancient architectural technology in terms of enduring and minimizing the earthquake damages. Many of the historical buildings in Kyoto and Nara were better preserved for it and such an ancient technology is used even in the present time, Tokyo Sky Tree, the highest tower in entire Asia located in Tokyo is a good example. My artistic interests are not limited to aesthetic cultures. In addition to the landscape architecture, I have broad interests with regard to other aspects of design. In school, I took part in many student activities, including the poster design, member’s clothes design, and magazine design. I am confident in saying that all these experiences I have make me highly flexible in adapting myself to different kinds of artistic cultures

1 Kudos

4.5 2 Skills

Ask Rate/Hr

Kevin J. Becker BUSINESS OPERATIONS ANALYST I am a trained Black Belt with a Master’s Degree in Operations Research and over 10-years of experience in the high-tech industry where I’ve led technical projects and programs for Executives concerned with the continuous improvement of business operations, product quality, and profitability SKILLS Performance Monitoring Ad hoc reporting, data mining, KPI metrics, dashboard design and development Prediction Modeling Data mining models, business simulations, forecasting Business Process Optimization Decision support application projects, black belt change management, six-sigma quality management PROFESSIONAL EXPERIENCE Brocade Communications Systems 2010—2011 Business Analyst Developed analytics for early warning of stressed customer accounts based on measures of abnormal service interruption frequency and problem resolution duration Developed a set of reports and dashboard for prioritization of service contract renewal workload and visualize contract renewal performance trends Developed analytics and leads for service uplift sales campaigns based on partner service escalation event frequency Hewlett-Packard Company 2002—2009 Internal Consultant Led a global team of subject matter experts and IT developers to author, validate, and implement a common set of sales performance metrics for the Global Services Sales VP Developed reports for the Regional Sales VPs that enabled their timely discovery of warranty conversion rate, retention rate, and sales growth trends Developed an analytical model to help the Global Services Finance VP determine how to best allocate and adjust headcount capacity across regions and service pillars Created a novel text data mining application for identification and recommendation of add-on services based on customer support event frequency and content Provided reporting used by HP Services to determine service partner quarterly payments based on integration of worldwide contracts data Compaq Computer Corporation 1997—2002 Master Black Belt Managed a major Enterprise Data Warehouse BI development project that consolidated all of Compaq’s direct and indirect channel partner service event transaction data—used the Earned Value Analysis project tracking methodology to monitor project schedule and cost which resulted in the successful delivery and completion of the project on time and within budget Developed a simulation model and metrics to predict/validate the ROI of knowledge centered support adoption in the mission-critical call center network that led to a 70% reduction in support cost per incident. Received an award from the Nonstop Engineering VP for my analytical support of a warranty cost reduction program initiative that achieved the lowest warranty cost as a percentage of revenue in the company Co-authored a seminal research paper on how best to dynamically allocate tasks to intelligent processors in various service settings as published in the European Journal of Operations Research Tandem Computers, Inc. 1994—1997 Quality Manager Architected the hardware and software quality metrics that were utilized by Tandem to manufacture commercial online transaction processing systems with the highest availability in computing industry Designed and managed the implementation a decision support application used by Engineering to more intelligently triage software change requests that resulted in the reduction of customer escalations to Senior Management Provided the Customer Support VP with accurate forecasts of annual workload based on installed base growth dynamics and corrective maintenance rates that were instrumental in achieving optimal customer support agent headcount EDUCATION M.S., Operations Research, 1986, Naval Postgraduate School B.S., Operations Research, 1979, United States Naval Academy METHODS & TOOLS Data Mining (Classification, Clustering, Prediction, RFM Analysis), Decision Analysis (Influence Diagrams, Decision Trees, Mathematical Programs & Optimization, System Dynamics), Earned Value Analysis (Project Management), Quality Improvement (Six-Sigma, Statistical Process Control) SQL Server 2008, T-SQL, Oracle OBIEE (10g Client), Business Objects (Web Intelligence User), GQL, Tableau (Professional Ed.), MS Access (data flows, macros, reports), MS Excel (Pivot Tables, Solver Optimization Models), MS Visio (ER Data Modeling), Analytica (Influence Diagrams, Decision Models, Monte-Carlo Simulations), Minitab (predictive analytics)